Search - tctmd.com

Displaying 1 - 20 of 54

Sort: Relevancy | Date

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

Presentation TCT 2024

TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

Presenter: Daria Feshchenko

October 28, 2024

Presentation TCT 2023

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

Presenter: David del Val

October 25, 2023

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

Presentation TCT 2021

TARGET AC 4-year Results & Deep Dive in Diabetes Subgroup

Presenter: Alexandra Lansky

November 06, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Presenter: Rafael Romaguera

November 04, 2021

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Conference News TCT 2021

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

Michael O'Riordan

October 15, 2021

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Todd Neale

October 21, 2020

Presentation TCT 2019

Leave It to the Endocrinologist!

Presenter: Sonya Burgess

September 27, 2019

Presentation TCT 2019

The Cardiologist Should Play a Major Role in Diabetes Management!

Presenter: Matthew Cavender

September 27, 2019

Presentation TCT 2019

Don't Forget Anticoagulant Therapy!

Presenter: Sanjit Jolly

September 27, 2019

Presentation TCT 2019

The Case for Short-Term (1-6 Months) DAPT

Presenter: Anand Prasad

September 27, 2019

Presentation TCT 2019

The Case for Long-Term (1 Year+) DAPT

Presenter: Usman Baber

September 27, 2019

Presentation TCT 2019

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Presenter: David Kandzari

September 27, 2019

Advertisement

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

What’s Going to Be Hot at TCT 2025

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

TARGET AC 4-year Results & Deep Dive in Diabetes Subgroup

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Good Long-term Results With FANTOM BVS, but More Data Needed

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Leave It to the Endocrinologist!

The Cardiologist Should Play a Major Role in Diabetes Management!

Don't Forget Anticoagulant Therapy!

The Case for Short-Term (1-6 Months) DAPT

The Case for Long-Term (1 Year+) DAPT

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content